Metraipolis › archive › dc_bf3a3648564e

Pharmacovigilance Data From Digital Health Systems: Regulations, Implications, and Opportunities-A TransCelerate Perspective — Europe PMC PMID:42081169

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42081169
DOI: 10.1007/s43441-[numero omesso]-7
License (as archived): solo-consultazione
Archived: 2026-11-02T19:16:35.762Z
SHA-256 of the archived text: c829b95f9d588d18d018d9bb8ca02ef0cbfcd104d8bff6a019c2a1854485b7f3
Stable URL of this page: https://metraipolis.com/documento/dc_bf3a3648564e

How to cite

Pharmacovigilance Data From Digital Health Systems: Regulations, Implications, and Opportunities-A TransCelerate Perspective — Europe PMC PMID:42081169 — Europe PMC (en), https://europepmc.org/article/MED/42081169 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf3a3648564e (Metraipolis archive dc_bf3a3648564e, sha256 c829b95f9d588d18d018d9bb8ca02ef0cbfcd104d8bff6a019c2a1854485b7f3)

BibTeX

@misc{dcbf3a3648564e,
  title = {Pharmacovigilance Data From Digital Health Systems: Regulations, Implications, and Opportunities-A TransCelerate Perspective — Europe PMC PMID:42081169},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42081169},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf3a3648564e; sha256 c829b95f9d588d18d018d9bb8ca02ef0cbfcd104d8bff6a019c2a1854485b7f3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42081169. Agents can read the archived copy with the MCP tool read_document.